{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:30:58Z","timestamp":1787243458526,"version":"build-2736575974"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1086\/324526","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:51:06Z","timestamp":1027687866000},"page":"S17-S26","source":"Crossref","is-referenced-by-count":67,"title":["Appropriate Use of Antimicrobials for Drug-Resistant Pneumonia: Focus on the Significance of \u03b2-Lactam\u2014Resistant Streptococcus pneumoniae"],"prefix":"10.1093","volume":"34","author":[{"suffix":"Jr.","given":"Thomas M.","family":"File","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"key\n\t\t\t\t20171014022614_ref1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014022614_ref2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.159.6.9808049","article-title":"Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae","volume":"159","author":"Ewig","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014022614_ref3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(67)92346-X","article-title":"A resistant pneumococcus","volume":"2","author":"Hansman","year":"1967","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014022614_ref6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/jac\/44.6.749","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated in the United States, 1997\u20131998","volume":"44","author":"Thornsberry","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014022614_ref7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014022614_ref8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study","volume":"43","author":"Jacobs","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014022614_ref9","first-page":"144","article-title":"Susceptibility of Streptococcus pneumonia, Haemophilus influenzae, and Moraxella catarhallis to oral agents: results of a 1998 U.S. outpatient surveillance study [abstract 144]","volume-title":"Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco)","author":"Jacobs","year":"1999"},{"issue":"1","key":"key\n\t\t\t\t20171014022614_ref10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/clinids\/24.Supplement_1.S85","article-title":"Antibiotic resistance in Streptococcus pneumoniae","volume":"24","author":"Tomasz","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"C","key":"key\n\t\t\t\t20171014022614_ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/28.suppl_C.31","article-title":"A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe","volume":"28","author":"Baquero","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014022614_ref12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref13","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJM200012283432610","article-title":"Managing antibiotic resistance","volume":"343","author":"Wenzel","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref14","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","article-title":"Drug-resistant Streptococcus pneumoniae","volume":"26","author":"Campbell","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00006454-199611000-00010","article-title":"Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin","volume":"15","author":"Dagan","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171014022614_ref16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1086\/514120","article-title":"Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?","volume":"176","author":"Dagan","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/clinids\/18.5.766","article-title":"Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae","volume":"18","author":"Catalan","year":"1994","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/clinids\/20.6.1572-a","article-title":"Drug-resistant pneumococcal meningitis in an American adult","volume":"20","author":"Cleveland","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0140-6736(92)90087-J","article-title":"Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis","volume":"339","author":"Friedland","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014022614_ref20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006454-199510000-00013","article-title":"Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease","volume":"14","author":"Friedland","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171014022614_ref21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/clinids\/18.2.188","article-title":"Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review","volume":"18","author":"John","year":"1994","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref22","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/AAC.39.9.1988","article-title":"Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis","volume":"39","author":"Klugman","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014022614_ref23","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"11th informational supplement","author":"National Committee for Clinical Laboratory Standards","year":"2001"},{"key":"key\n\t\t\t\t20171014022614_ref24","first-page":"920","article-title":"Antibiotic-resistant pneumococcal disease in South African children","volume":"146","author":"Friedland","year":"1992","journal-title":"Am J Dis Child"},{"key":"key\n\t\t\t\t20171014022614_ref25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/516340","article-title":"Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children","volume":"26","author":"Choi","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/peds.103.2.409","article-title":"Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group","volume":"103","author":"Deeks","year":"1999","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20171014022614_ref28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171014022614_ref29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJM198509053131006","article-title":"Community-acquired pneumonia due to penicillin-resistant pneumococci","volume":"313","author":"Feldman","year":"1985","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM198707023170104","article-title":"Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci","volume":"317","author":"Pallares","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0163-4453(87)92127-X","article-title":"Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus","volume":"14","author":"Sacho","year":"1987","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20171014022614_ref32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20171014022614_ref33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence","volume":"29","author":"Turett","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"key\n\t\t\t\t20171014022614_ref35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/45.suppl_3.79","article-title":"Comparative in vivo activity of gemifloxacin in a rat model of respiratory tract infection","volume":"45","author":"Berry","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014022614_ref36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00001432-200104000-00011","article-title":"Streptococcus pneumoniae respiratory tract infections","volume":"14","author":"Klugman","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref38","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.112.6.1657","article-title":"Penicillin dosing for pneumococcal pneumonia","volume":"112","author":"Bryan","year":"1997","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171014022614_ref39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1542\/peds.99.2.289","article-title":"Therapy for children with invasive pneumococcal infections","volume":"99","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"1997","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20171014022614_ref40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM197708252970802","article-title":"A pharmacologic evaluation of penicillin in children with purulent meningitis","volume":"297","author":"Hieber","year":"1977","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20171014022614_ref41","first-page":"7","article-title":"Choosing an antibiotic on the basis of pharmacodynamics","volume":"77","author":"Craig","year":"1998","journal-title":"Ear Nose Throat J"},{"key":"key\n\t\t\t\t20171014022614_ref42","first-page":"57","article-title":"Surveillance of multiple drug resistance patterns among Streptococcus pneumoniae in the United States [abstract 96]","volume-title":"Program and abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America (New Orleans)","author":"Selman","year":"2000"},{"key":"key\n\t\t\t\t20171014022614_ref43","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1378\/chest.113.2.412","article-title":"The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia","volume":"113","author":"Kollef","year":"1998","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171014022614_ref45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/rmed.1999.0775","article-title":"Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation","volume":"94","author":"Ewig","year":"2000","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20171014022614_ref46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022614_ref47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1183\/09031936.98.11040986","article-title":"ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections","volume":"11","author":"European Respiratory Society","year":"1998","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20171014022614_ref48","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171014022614_ref49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jama.283.6.749","article-title":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia","volume":"283","author":"Marrie","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014022614_ref50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0149-2918(00)88483-0","article-title":"Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin","volume":"22","author":"Palmer","year":"2000","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20171014022614_ref51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3201\/eid0702.010228","article-title":"Economic impact of antimicrobial resistance","volume":"7","author":"McGowan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014022614_ref52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1378\/chest.115.suppl_1.3S","article-title":"Overview of resistance in the 1990s","volume":"115","author":"File","year":"1999","journal-title":"Chest"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/34\/Supplement_1\/S17\/20904042\/34-Supplement_1-S17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T22:41:05Z","timestamp":1583275265000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/34\/Supplement_1\/S17\/509987\/Appropriate-Use-of-Antimicrobials-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":52,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2002,3,1]]},"published-print":{"date-parts":[[2002,3,1]]}},"URL":"https:\/\/doi.org\/10.1086\/324526","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2002,3,1]]},"published":{"date-parts":[[2002,3,1]]}}}